Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Astrea Bioseparations delivers advanced chromatography resins, adsorbents, columns, and nanofiber-based devices to enable efficient separation and purification of proteins, viral vectors, exosomes, plasmid DNA and other biomolecules. Their technologies support FDA/EMA-approved manufacturing processes globally. Recent innovations include scalable solutions tailored to cell and gene therapy production.
The company does not conduct clinical trials or have a therapeutic pipeline; its impact lies in supporting drug developers with high-quality bioseparation tools.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Astrea Bioseparations.